InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the complete record of transactions filed by Scott John K Jr., Director. Director active across 1 companies, notably Navidea Biopharmaceuticals, INC.. Cumulatively, 10 filings have been published. The latest transaction was filed on 31 May 2022 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Declarations10 total
02,500 shares0
Common Stock
SEC:0001437749-22-014045:0·
02,500 shares0
Common Stock
SEC:0001437749-22-010726:0·
02,500 shares0
Common Stock
SEC:0001437749-22-007860:0·
02,500 shares0
Common Stock
SEC:0001437749-22-004850:0·
02,500 shares0
Common Stock
SEC:0001437749-22-002110·
02,500 shares0
Common Stock
SEC:0001437749-22-002110:0·
02,500 shares0
Common Stock
SEC:0001437749-22-000324·
02,500 shares0
Common Stock
SEC:0001437749-22-000324:0·
€2630,000 shares@ €0.0009100.0% of flow
Common Stock
SEC:0001437749-21-027696·
€2630,000 shares@ €0.000950.0% of flow
Common Stock
SEC:0001437749-21-027696:0·
10 of 10 declarations
About Scott John K Jr.
John K. Scott Jr. is a Board Member at NAVIDEA BIOPHARMACEUTICALS, INC. As a board member, he contributes to the strategic direction of the company. His experience in the biopharmaceutical sector is valuable in guiding decisions and ensuring regulatory compliance. He plays an active role in evaluating the company's performance and overseeing its operations.
